News|Articles|August 5, 2025

Cannabis Company Ayr Wellness Announces Restructuring Support Agreement

Author(s)Erin McEvoy
Listen
0:00 / 0:00

Key Takeaways

  • Ayr Wellness Inc. has entered a Restructuring Support Agreement with senior noteholders to reduce debt and maximize stakeholder value.
  • The agreement includes an Article 9 sale process, allowing noteholders to purchase assets in multiple states and assume liabilities.
SHOW MORE

Ayr Wellness secures support from a majority of senior noteholders, outlining a restructuring plan to stabilize operations and reduce debt.

In a July 30, 2025, press release, vertically integrated US cannabis company Ayr Wellness Inc. announced it had entered into a Restructuring Support Agreement (RSA) with a committee of its senior noteholders (1). The RSA involves a plan to continue the company’s operations and transition of its business under its new ownership.

“Today marks a major milestone for AYR and the restructuring of its obligations, having agreed to a pathway to reduce its debt and seek to maximize value for all stakeholders,” stated Scott Davido, Interim Chief Executive Officer of AYR, in the press release. “We look forward to continuing to work closely with our lenders as we execute the next steps in our restructuring plan as defined by the RSA.”

As explained in the press release, Ayr Wellness will support an Article 9 Uniform Commercial Code sale process to the senior noteholders, who have agreed to purchase assets in Florida, Ohio, Nevada, New Jersey, Pennsylvania, and Virginia as assume certain liabilities. The remaining assets are anticipated to be evaluated for sale or wind-down.

Additionally, a Bridge Facility, a senior secured multiple draw term loan facility, will be provided by the committee in order to fund operations, conduct the Article 9 sale, and complete other transactions. The loan will be for up to $50 million at 14% interest per annum. Once the asset transactions are completed, the debt will be converted into “Take-Back Debt Facility.”

After the Article 9 sale ends, the company will pursue a court-supervised liquidation in British Columbia under the Companies’ Creditors Arrangement Act. The US subsidiaries will wind-down their operations in the various states. The liquidation proceeds from the remaining assets will be distributed among the creditors.

Ayr Wellness also operates more than 90 dispensary locations and includes the brands kynd, HAZE, Later Days, and Levia (2).

Reference

  1. Ayr Wellness. AYR Wellness Enters Into Restructuring Support Agreement with Senior Noteholders https://www.globenewswire.com/news-release/2025/07/30/3124507/0/en/AYR-Wellness-Enters-Into-Restructuring-Support-Agreement-with-Senior-Noteholders.html (accessed August 5, 2025).
  2. Ayr Wellness. Our Brands. https://ayrwellness.com/brands/ (accessed August 5, 2025).

Related to this article

2025 Medical Cannabis Roundup
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Image | adobe.stock/Stock Rocket
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
Manipulating Cannabis Genetics: Pulling Levers to Increase  Phytochemical Composition
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
Image | adobe.stock/Maksim Kabakou
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!